An antibody discovery platform revealed more than 60 monoclonal antibodies specific to patients with alpha-gal syndrome, according to a poster presented here. This molecular characterization may ...

An immune system defect makes affected individuals vulnerable to severe viral diseases such as influenza or COVID-19. It is ...

A new study offers hope in the fight against flesh-eating fungus infections. Researchers have discovered a promising antibody ...

Glucagon-like peptide-1 (GLP-1) receptor agonists are peptide-based therapeutics for treating diabetes and for weight loss.

Findings on golidocitinib for patients with non-small cell lung cancer whose disease has progressed on anti-PD-1 therapy will ...

Antibody-drug conjugates have had a tremendous impact on breast cancer care and treatment, according to Dr. Charles E. Geyer.

As a result, Ibrahim and Gu developed an antibody called VX-01, a humanized antibody that has proven more effective at ...

Tharimmune, Inc. (Nasdaq:THAR) (”Tharimmune” or the “Company”), a clinical-stage biotechnology company focused on immunology and inflammation, today announced positive preclinical results for its ...

Researchers have identified antibodies that could lead to a broadly protective norovirus vaccine and new treatment options.

After spending years unsuccessfully attempting to develop a Covid-19 vaccine, Inovio is now reporting promising results from early testing of an experimental Covid treatment.

On , US time, the world's first acute myocardial infarction (AMI) antibody drug, SGC001, developed by Sungen Biomedical-an innovative biopharmaceutical company incubated by Beijing Hotgen Biotech Co., ...